Email Updates

You are here

Home»Trial Summary Table

Trial Summary Table

Trial Name Phase Start Date Sponsors Countries Population Candidate(s) Status Expected Completion Date
MK-8591-016 II Friday, September 13, 2019 United States of America, Malawi, South Africa, Israel Men Islatravir (MK-8591) Stopped Early March 2022
MTN 003 (VOICE) IIb Saturday, August 1, 2009 MTN, NIAID, CONRAD, Gilead, MMH, NICHD South Africa, Zimbabwe, Uganda Women TDF, TDF/FTC (Truvada), 1% tenofovir gel Completed August 2012
MTN 003D Other Wednesday, December 26, 2012 MTN; NIAID (DAIDS-ES: 11893); NIH (5UM1AI068633) ; NICHD; NIMH South Africa, Uganda, Zimbabwe Women Completed March 2014
MTN 016 (EMBRACE) Open Label Saturday, October 31, 2009 MTN, NIAID, CONRAD, NICHD United States of America, Zimbabwe, South Africa, Malawi, Uganda Pregnant women Ongoing November 2020
MTN 017 II Monday, September 30, 2013 CONRAD, MTN, NIAID, NIMH Thailand, South Africa, United States of America, Puerto Rico, Peru MSM Reduced Glycerin 1% Tenofovir Gel, TDF/FTC (Truvada) Completed May 2015
MTN 034 / IPM 045 / REACH II Monday, January 14, 2019 NIAID (DAIDS-ES: 12066), NICHD, NIMH, NIH, IPM South Africa, Kenya, Zimbabwe, Uganda Women Dapivirine Ring, TDF/FTC (Truvada) Ongoing October 2021
MTN-003C (VOICE Community Substudy) Other Tuesday, June 15, 2010 DAIDS;NIH;NIAID South Africa Women Completed July 2012
MTN-041/ MAMMA Other Thursday, May 31, 2018 NIAID (DAIDS-ES: 38161) Malawi, South Africa, Uganda, Zimbabwe Women Dapivirine Ring, TDF/FTC (Truvada) Ongoing November 2018
Nigerian National Agency for the Control of AIDS Demo Project Tuesday, December 1, 2015 Bill & Melinda Gates Foundation Nigeria Women, Men Planned December 2017
NYC PrEP (PrEPared & Strong) Demo Project Monday, March 16, 2015 NIMH, Columbia University, Gilead United States of America MSM Ongoing July 2017

Pages